Biomarkers Cancer|Biotechnology Market Research Reports|Biomarkers Market Research Reports

Brand Principles
Bioimaging

Market Research Report - BIO-IMAGING

For list of other market reports click here

(Published by RI Technologies - May '08 - No. of pages: 317)

  • Description
  • Free Samples
  • Summary
  • Companies Mentioned
  • Buy Report

This market research report on Bio-imaging focuses on the different types and modalities of bio-imaging and their application in Research and Development and Diagnostics. The study provides global market analysis for bio-imaging by Type (Medical and Molecular) and Modalities including Ultrasound, CT, MRI, PET, SPECT and other modalities comprising X-Ray, TEM and OCT. The research study includes estimates and projections for the total global bio-imaging market. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions (M & A) is covered in the research report. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Japan, Asia-Pacific, Latin America, and rest of world with 276 exclusive graphically represented exhibits.


The Biomedical Imaging stream would evolve as a pillar for diagnosis; this further improves other techniques that play a competitive role in imaging. The imaging market is growing - from US$16.7 billion in 2005 it is projected to reach US$27.4 billion by 2012 with a 7.3% growth rate hence showing the potential of imaging as a research tool in the market. This focus on the medical market gives rise to many innovative tools and business opportunities. North America is the leading market (46.5% of global market share in 2006) for Bioimaging presently and is projected to manage the leading position throughout the analysis period with its share dropping to 42.8% by 2012. Due to heavy demand and access to the latest technology, Japan is the fastest growing (8.8% during 2005-2012) market for Bioimaging which is closely followed by Asia-Pacific.

Major Companies such as GE Healthcare (UK), Siemens, Bayer Schering (Germany), Hologic, Mallinckrodt (USA), Esaote SpA (Italy), Hitachi, Shimadzu (Japan) hold major shares in the Bioimaging market. Competition is very high due to the high demand of these products.Biomedical imaging is a combination of medical disciplines and other life sciences. It offers the full potential to produce sophisticated imaging tools; which includes both quality and accessibility. The improvements made for treating of living organisms are associated with integrated image-guided therapy. This further increases the chances of treatments and diagnosis in the health sector. There is an adequate need for development of new imaging techniques. With the drastic development in Cell Biology, Biochemistry, and also in computer analysis, use of molecular imaging technologies has increased exponentially in recent years. Even though only 13.4% of global imaging procedures are truly molecular, the compounded annual market growth rates are expected to be around 15.6%.

Countries Mentioned:
United States
Canada
Germany
United Kingdom
France
Italy
Rest of Europe
Japan
Asia-Pacific
Australia
China
India
Rest of Asia-Pacific
Brazil
Mexico
Rest of Latin America
Rest of World

- Advanced Research Technologies, Inc. (Canada)
- Analogic Corporation (USA)
- Bayer Schering Pharma AG (Germany)
- Bio-Imaging Technologies, Inc. (USA)
- Bracco Group (Italy)
- Carestream Health, Inc. (USA)
- Carl Zeiss SMT AG (Germany)
- CellPoint LLC (USA).
- Del Global Technologies Corporation (USA)
- Draxis Health, Inc. (Canada)
- Esaote SpA (Italy)
- FEI Company (USA)
- FOCUS GmbH (Germany)
- FONAR Corporation (USA)
- Gamma Medica – Ideas, Inc. (USA)
- GE Healthcare (UK)
- Genetix Ltd. (UK)
- Guerbet SA (France)
- Hitachi Medical Corporation (Japan)
- Hologic, Inc. (USA)
- IMIX ADR Ltd. (Finland)
- InfiMed, Inc. (USA)
- IRIS International, Inc. (USA)
- JEOL, Ltd. (Japan)
- Kereos, Inc. (USA)
- Koninklijke Philips Electronics NV (The Netherlands)
- Lantheus Medical Imaging (USA)
- Mallinckrodt, Inc. (USA)
- Medison Co. Ltd (South Korea)
- Mindray Bio-Medical Electronics Co., Ltd. (China)
- Neusoft Group Ltd. (China)
- Polartechnics Limited (Australia)
- Shimadzu Corporation (Japan)
- Siemens AG (Germany)
- SonoSite, Inc. (USA)
- Swissray Medical AG (Switzerland)
- The Samon Imaging Systems (India)
- VisEn Medical, Inc. (USA)
- VisualSonics, Inc. (Canada).
- VMI - Sistemas Médicos (Brazil)

Single Site License-US$ 4200

Global Site License-US$ 8800

For those who are intrested to buy the report by chapter:

CHAPTER

TITLE

SHORT DESCRIPTION

PRICE (US$)

I

Scope and Methodology

This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
* Will be delivered free with purchase of any of the other chapters mentioned below.

FREE*

II

Report Synopsis

Report synopsis summarizes the global bio-imaging market by Types, Applications and Modalities. The chapter also includes a global list of major players and market analysis by geographic regions including North America, Europe, Japan, Asia-Pacific, Latin America and rest of world.

$1150

 

III

Product / Technology Research

This chapter gives an insight into bio-imaging market including definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012). The chapter also includes product trends and potential opportunities of bio-imaging in various Life Sciences applications.

$1000

 

IV

Market Dynamics

Market Dynamics chapter provides information on global markets for Bio-imaging. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by type, application and modalities; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc.

$2250

 

V

Corporate Directory

This chapter provides a region-wise list of 186 companies, CROs and academic institutions that are engaged in bio-imaging products and/or services.

$300